Deepika Kumar, MD
Assistant Professor of PathologyDownloadHi-Res Photo
Cards
Appointments
Pathology
Primary
Contact Info
Pathology
310 Cedar Street, PO Box 208023
New Haven, CT 06510
United States
About
Copy Link
Titles
Assistant Professor of Pathology
Biography
Deepika Kumar received her medical school degree and completed a pathology residency from University of Mumbai, India. Thereafter, she did her residency training in Anatomic and Clinical Pathology at Yale New Haven Hospital in 2020, where she also served as a Chief resident (2019-20). She subsequently completed fellowship trainings in Hematopathology (2021), followed by Renal and Genitourinary pathology (2022), both at Yale. She is board-certified in Anatomic and Clinical Pathology and Hematopathology.
Last Updated on March 16, 2025.
Appointments
Pathology
Assistant ProfessorPrimary
Other Departments & Organizations
- Genitourinary Pathology
- Hematopathology
- Hematopathology
- Pathology
- Yale Medicine
- Yale New Haven Health System
Education & Training
- Clinical Fellow
- Yale-New Haven Hospital (2022)
- Clinical Fellow
- Yale-New Haven Hospital (2021)
- Chief Resident
- Yale-New Haven Hospital (2020)
- Residency
- Yale-New Haven Hospital (2019) (2019)
- MD
- University of Mumbai, Pathology (AP/CP) (2007)
- Residency
- L.T.M.M.C (University of Mumbai)
- MD
- Government Medical School (2004)
Research
Copy Link
Research at a Glance
Yale Co-Authors
Frequent collaborators of Deepika Kumar's published research.
Publications Timeline
A big-picture view of Deepika Kumar's research output by year.
Mina Xu, MD
Adebowale Adeniran, MD
Guoping Cai, MD, MS
David Rimm, MD, PhD
David Schoenfeld, MD, PhD
Demetrios Braddock, MD, PhD
11Publications
169Citations
Publications
Featured Publications
Can primary hepatocellular carcinoma histomorphology predict extrahepatic metastasis?
Kumar D, Hafez O, Jain D, Zhang X. Can primary hepatocellular carcinoma histomorphology predict extrahepatic metastasis? Human Pathology 2021, 113: 39-46. PMID: 33905775, DOI: 10.1016/j.humpath.2021.04.008.Peer-Reviewed Original ResearchCitationsMicroenvironment Cell Contribution to Lymphoma Immunity
Kumar D, Xu ML. Microenvironment Cell Contribution to Lymphoma Immunity. Frontiers In Oncology 2018, 8: 288. PMID: 30101129, PMCID: PMC6073855, DOI: 10.3389/fonc.2018.00288.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricClinicopathological Review of Micropapillary Urothelial Carcinoma
Kumar D, Adeniran AJ. Clinicopathological Review of Micropapillary Urothelial Carcinoma. Current Oncology Reports 2022, 24: 603-610. PMID: 35199295, DOI: 10.1007/s11912-022-01219-x.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsBenign lymph node microenvironment is associated with response to immunotherapy
Toki MI, Kumar D, Ahmed FS, Rimm DL, Xu ML. Benign lymph node microenvironment is associated with response to immunotherapy. Precision Clinical Medicine 2020, 3: 44-53. PMID: 35693430, PMCID: PMC8985791, DOI: 10.1093/pcmedi/pbaa003.Peer-Reviewed Original ResearchCitationsAltmetric
2025
Plasmacytoid dendritic cell clusters are associated with poor prognosis in chronic myelomonocytic leukemia
Kumar D, Cheng W, Lin L, Raess P, Xie W, Wong J, Daneshpajouhnejad P, Fathalla L, Morgan E, Bagg A, Hasserjian R, Katz S, Xu M. Plasmacytoid dendritic cell clusters are associated with poor prognosis in chronic myelomonocytic leukemia. Virchows Archiv 2025, 1-6. PMID: 41247506, DOI: 10.1007/s00428-025-04333-w.Peer-Reviewed Original ResearchCitationsAltmetricClinicopathologic characteristics of lymphoproliferative disorders involving the kidney
Takeda K, Tang H, Kumar D, Adeniran A, Cai G. Clinicopathologic characteristics of lymphoproliferative disorders involving the kidney. American Journal Of Clinical Pathology 2025, 164: 192-199. PMID: 40418705, DOI: 10.1093/ajcp/aqaf023.Peer-Reviewed Original ResearchCitations
2024
A dual-acting DNASE1/DNASE1L3 biologic prevents autoimmunity and death in genetic and induced lupus models
Sims D, Gomez-Bañuelos E, Zehentmeier S, Dammen-Brower K, Bernhisel A, Kujawski S, Lopez S, Petri M, Goldman D, Lester E, Le Q, Ishaq T, Kim H, Kumar D, Pereira J, Yarema K, Koumpouras F, Andrade F, Braddock D. A dual-acting DNASE1/DNASE1L3 biologic prevents autoimmunity and death in genetic and induced lupus models. JCI Insight 2024, 9: e177003. PMID: 38888971, PMCID: PMC11383374, DOI: 10.1172/jci.insight.177003.Peer-Reviewed Original ResearchCitationsAltmetric
2022
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance
Schoenfeld D, Moutafi M, Martinez S, Adeniran A, Kumar D, Jilaveanu L, Hurwitz M, Rimm D, Kluger H. Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance. Frontiers In Oncology 2022, 12: 990367. PMID: 36313654, PMCID: PMC9608089, DOI: 10.3389/fonc.2022.990367.Peer-Reviewed Original ResearchCitationsAltmetric
2019
Cryoglobulinemia as a Possible Primer for TRALI: Report of a Case
Beech C, Kumar D, Hendrickson J, Perincheri S, Tormey C, Bahar B. Cryoglobulinemia as a Possible Primer for TRALI: Report of a Case. Lab Medicine 2019, 50: 313-319. PMID: 30657960, DOI: 10.1093/labmed/lmy073.Peer-Reviewed Original ResearchCitationsAltmetric
2018
Corrigendum: Microenvironment Cell Contribution to Lymphoma Immunity
Kumar D, Xu ML. Corrigendum: Microenvironment Cell Contribution to Lymphoma Immunity. Frontiers In Oncology 2018, 8: 522. PMID: 30460201, PMCID: PMC6237016, DOI: 10.3389/fonc.2018.00522.Commentaries, Editorials and LettersAltmetric
News
Copy Link
News
Get In Touch
Copy Link
Contacts
Mailing Address
Pathology
310 Cedar Street, PO Box 208023
New Haven, CT 06510
United States
Administrative Support
Locations
Brady Memorial Laboratory
Academic Office
310 Cedar St
New Haven, CT 06510